ReviewExpert opinion on investigational drugs2009

The development of antibody-IL-2 based immunotherapy with hu14.18-IL2 (EMD-273063) in melanoma and neuroblastoma.

Brett H Yamane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.